Vedolizumab does not increase risk of C. diff infection in UCJanuary 3, 2022IBD & Intestinal Disorders
Ulcerative colitis: Donor-derived strains predict response in FMTNovember 30, 2021IBD & Intestinal Disorders
People of color missing in inflammatory bowel disease trialsNovember 29, 2021IBD & Intestinal Disorders
Whole-food exclusion diet effective for adult Crohn’s diseaseNovember 29, 2021IBD & Intestinal Disorders
Upadacitinib delivers rapid response in ulcerative colitisNovember 15, 2021IBD & Intestinal Disorders
Risankizumab has early and lasting benefits in Crohn’s diseaseNovember 10, 2021IBD & Intestinal Disorders
Newly discovered vascular barrier in the brain may explain IBD-related anxiety, depressionNovember 8, 2021IBD & Intestinal Disorders
AGA Clinical Practice Update: Managing pain in gut-brain interaction disordersNovember 8, 2021IBD & Intestinal Disorders
Definitive diverticular hemorrhage: Diagnosis and managementNovember 2, 2021IBD & Intestinal Disorders
Immune response detected in most IBD patients after COVID vaccinesOctober 28, 2021COVID-19 UpdatesIBD & Intestinal Disorders
A pill for C. difficile works by increasing microbiome diversityOctober 27, 2021IBD & Intestinal Disorders
UC relapse associated with impaired luminal control of macrophage maturationOctober 18, 2021IBD & Intestinal Disorders
In Crohn’s disease, no decline in stomas despite increasing use of anti-TNFOctober 12, 2021IBD & Intestinal Disorders
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACsOctober 11, 2021IBD & Intestinal DisordersUpper GI Tract
